| |
| |
|
| Insider
Information: |
Scibetta James S |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
770,845 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$926,101 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
770,845 |
|
|
| Total
Value |
$926,101 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pacira Pharmaceuticals, Inc. |
PCRX |
President |
2017-06-05 |
25,118 |
2011-02-15 |
0 |
Premium* |
|
|
Nephros Inc |
NEPH |
Director |
2013-08-20 |
64,134 |
2013-05-23 |
0 |
Premium* |
|
|
Matinas Biopharma Holdings, Inc. |
MTNB |
Director |
2021-06-19 |
649,958 |
|
0 |
Premium* |
|
|
Aquestive Therapeutics, Inc. |
AQST |
|
2019-08-21 |
31,635 |
2019-08-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2017-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
413,309 |
|
- |
|
| NEPH |
Nephros Inc |
Director |
– • – |
2013-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
52,056 |
52,056 |
0 |
- |
|
| NEPH |
Nephros Inc |
Director |
– • – |
2013-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,078 |
64,134 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
President & CFO |
• – – |
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
26,754 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2018-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
24,672 |
442,981 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
43,203 |
486,184 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,381 |
506,565 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2018-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
31,513 |
538,078 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
17,202 |
555,280 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,400 |
609,298 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
21,879 |
577,159 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
29,739 |
606,898 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8,260 |
617,558 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2020-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,600 |
621,158 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2021-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,800 |
625,958 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2021-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
649,958 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2017-09-07 |
4 |
B |
$1.29 |
$6,450 |
D/D |
5,000 |
418,309 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2013-03-28 |
4 |
OE |
$1.61 |
$16,100 |
D/D |
10,000 |
15,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2013-06-28 |
4 |
OE |
$1.61 |
$16,100 |
D/D |
10,000 |
15,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2013-09-30 |
4 |
OE |
$1.61 |
$16,100 |
D/D |
10,000 |
15,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2013-12-30 |
4 |
OE |
$1.61 |
$16,100 |
D/D |
10,000 |
15,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
SVP, Chief Financial Officer |
• – – |
2014-05-08 |
4 |
OE |
$1.61 |
$24,150 |
D/D |
15,000 |
20,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
SVP, Chief Financial Officer |
• – – |
2014-08-08 |
4 |
OE |
$1.61 |
$24,150 |
D/D |
15,000 |
20,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
SVP, Chief Financial Officer |
• – – |
2014-11-07 |
4 |
OE |
$1.61 |
$24,150 |
D/D |
15,000 |
20,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
SVP, Chief Financial Officer |
• – – |
2015-02-06 |
4 |
OE |
$1.61 |
$24,150 |
D/D |
15,000 |
20,230 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
